130 related articles for article (PubMed ID: 20734714)
21. The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden.
Naucler P; Henriques-Normark B; Hedlund J; Galanis I; Granath F; Örtqvist Å
J Intern Med; 2019 Dec; 286(6):689-701. PubMed ID: 31278792
[TBL] [Abstract][Full Text] [Related]
22. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
23. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.
Pírez MC; Algorta G; Cedrés A; Sobrero H; Varela A; Giachetto G; Montano A
Pediatr Infect Dis J; 2011 Aug; 30(8):669-74. PubMed ID: 21407145
[TBL] [Abstract][Full Text] [Related]
24. Lack of effectiveness of the 23-valent polysaccharide pneumococcal vaccine in reducing all-cause pneumonias among healthy young military recruits: a randomized, double-blind, placebo-controlled trial.
Russell KL; Baker CI; Hansen C; Poland GA; Ryan MA; Merrill MM; Gray GC
Vaccine; 2015 Feb; 33(9):1182-7. PubMed ID: 25579777
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population.
Castañeda-Orjuela C; Alvis-Guzmán N; Paternina AJ; De la Hoz-Restrepo F
Vaccine; 2011 Oct; 29(44):7644-50. PubMed ID: 21854825
[TBL] [Abstract][Full Text] [Related]
26. Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination.
Balicer RD; Zarka S; Levine H; Klement E; Sela T; Porat N; Ash N; Dagan R
Vaccine; 2010 Aug; 28(34):5591-6. PubMed ID: 20599301
[TBL] [Abstract][Full Text] [Related]
27. Pneumococcal vaccines and the prevention of community-acquired pneumonia.
Esposito S; Principi N
Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597
[TBL] [Abstract][Full Text] [Related]
28. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
29. [Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
Redondo E; Rivero-Calle I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Gil A; Molina J; Jimeno I; Ocaña D; Yuste JE; Martinón-Torres F;
Semergen; 2018; 44(8):590-597. PubMed ID: 30318406
[TBL] [Abstract][Full Text] [Related]
30. Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001-2014).
Jimenez Trujillo I; Lopez de Andres A; Hernandez-Barrera V; Martinez-Huedo MA; de Miguel-Diez J; Jimenez-Garcia R
Vaccine; 2017 Jun; 35(30):3733-3740. PubMed ID: 28558982
[TBL] [Abstract][Full Text] [Related]
31. [Current approaches to managing patients with extra-hospital pneumonia in military collectives].
Guchev IA; Sinopal'nikov AI; Ul'ianov VA; Klochkov OI
Voen Med Zh; 2001 Nov; 322(11):29-35. PubMed ID: 11871057
[No Abstract] [Full Text] [Related]
32. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
[TBL] [Abstract][Full Text] [Related]
33. Community-acquired pneumonia.
Andrews J; Nadjm B; Gant V; Shetty N
Curr Opin Pulm Med; 2003 May; 9(3):175-80. PubMed ID: 12682561
[TBL] [Abstract][Full Text] [Related]
34. Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study.
Palmu AA; Saukkoriipi A; Snellman M; Jokinen J; Torkko P; Ziegler T; Kaijalainen T; Hausdorff WP; Verlant V; Kilpi TM
Scand J Infect Dis; 2014 Apr; 46(4):250-9. PubMed ID: 24475952
[TBL] [Abstract][Full Text] [Related]
35. Community acquired pneumonia in children.
Haq IJ; Battersby AC; Eastham K; McKean M
BMJ; 2017 Mar; 356():j686. PubMed ID: 28255071
[No Abstract] [Full Text] [Related]
36. Managing community-acquired pneumonia during flu season.
Haessler S; Schimmel JJ
Cleve Clin J Med; 2012 Jan; 79(1):67-78. PubMed ID: 22219236
[TBL] [Abstract][Full Text] [Related]
37. [Improvement of epidemiological surveillance of meningococcus infection and it's selective prophylaxis in troops].
Ogarkov PI; Belov AB; Korotchenko SI; Kharchenko VI
Voen Med Zh; 2009 Aug; 330(8):55-61. PubMed ID: 19916316
[TBL] [Abstract][Full Text] [Related]
38. [Experience of application of the PCR for identification of the causative agent of community acquired pneumonia in the military.].
Speranskaya EV; Brusnigina NF; Efimov EI; Samokhina LP
Klin Lab Diagn; 2018; 63(10):641-645. PubMed ID: 30768887
[TBL] [Abstract][Full Text] [Related]
39. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Webber C; Patton M; Patterson S; Schmoele-Thoma B; Huijts SM; Bonten MJ;
Vaccine; 2017 Mar; 35(9):1266-1272. PubMed ID: 28173960
[TBL] [Abstract][Full Text] [Related]
40. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
